[Cycloferon efficacy in the treatment of acute respiratory tract viral infection and influenza during the morbidity outbreak in 2009-2010].

Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virus. J Prev Med Hyg (2014) 0.81

[Antioxidant and membranoprotector treatment of chronic pyelonephritis]. Eksp Klin Farmakol (2011) 0.76

[The therapeutic efficacy of cycloferon and the pharmacological activity of interferon inducers]. Ter Arkh (2014) 0.75

[Induction of endogenous s-adenosyl-l-methionine in hepatocytes during pharmacological correction of experimental acute toxic and chronic drug-induced liver injury]. Eksp Klin Farmakol (2011) 0.75

[The influence of citoflavin on molecular mechanisms of hypertensive encephalopathy development in patients with systolic arterial hypertension]. Eksp Klin Farmakol (2014) 0.75

[Cycloferon in complex therapy management of chronic laryngitis]. Antibiot Khimioter (2013) 0.75

[Cycloferon efficacy of therapy of chronic hepatitis B (results of randomized multicentre study)]. Antibiot Khimioter (2010) 0.75

[An experimental study of the efficiency of cycloferon in the complex chemotherapy of generalized drug-resistant tuberculosis]. Eksp Klin Farmakol (2012) 0.75

[Cycloferon in emergency prophylaxis of respiratory viral infections and influenza]. Klin Med (Mosk) (2011) 0.75

[Interferon inductor activity and interferon production under the action of acridonacetic acid salts]. Eksp Klin Farmakol (2014) 0.75

[Induction of type 1, 2 and 3 interferons by acridone acetates]. Antibiot Khimioter (2014) 0.75

[Cycloferon efficacy in viral and bacterial diseases of children (clinical review)]. Antibiot Khimioter (2010) 0.75

[Frequently ill child syndrome]. Antibiot Khimioter (2012) 0.75

[Pathogenetic correction of metabolic disturbances in chronic liver affections]. Antibiot Khimioter (2012) 0.75

[Cycloferon in therapy of hyperplastic laryngitis for decrease of the number of relapses]. Eksp Klin Farmakol (2013) 0.75

[Immunotropic therapy of arbovirus infections in children]. Antibiot Khimioter (2013) 0.75

[Experimental study of cytoprotector effect of succinate-containing drugs on functional activity of liver]. Eksp Klin Farmakol (2010) 0.75

[Pathogenetic therapy of tuberculosis of respiratory organs during sanatorium-and-spa treatment]. Vopr Kurortol Fizioter Lech Fiz Kult (2009) 0.75

[The study of dynamics of clinical and molecular phenotypes in the generalized form of myasthenia with optimized and combined treatment]. Vestn Ross Akad Med Nauk (2013) 0.75

[Hepatoprotective activity of remaxol in patients with chronic hepatic disorders]. Klin Med (Mosk) (2010) 0.75

[Clinico-immunological and epidemiological characteristics of acute viral hepatitis in children in the first 3 years of life]. Pediatriia (1982) 0.75

[Problems in treating influenza and acute respiratory infection in children]. Eksp Klin Farmakol (2011) 0.75

[Efficiency of remaxol in preventing unwanted side effects of the antiviral therapy in patients with chronic hepatitis C]. Eksp Klin Farmakol (2013) 0.75

[Proteomic profile and non-specific immunoprophylaxis of respiratory diseases in frequently sick children]. Vestn Ross Akad Med Nauk (2012) 0.75

[Monitoring of side effects and estimation of cycloferon efficacy in treatment of children with frequent and prolonged diseases]. Antibiot Khimioter (2012) 0.75

[Type 1 and type 2 interferon inductor (cycloferon) in therapy of children with pyelonephritis associated with herpes viruses]. Antibiot Khimioter (2009) 0.75

[Experimental and clinicolaboratory evaluation of complex therapy efficacy in arboviral infections]. Antibiot Khimioter (2012) 0.75

[Cycloferon as an agent for the anti-relapse therapy in patients with chronic hyperplastic sinusitis]. Antibiot Khimioter (2013) 0.75

[Minimization of endogenous intoxication syndrome by individual choice of drugs for therapy of chronic hepatitis]. Antibiot Khimioter (2011) 0.75

[Improvement of treatment of inflammatory diseases in oral cavity]. Eksp Klin Farmakol (2011) 0.75

[Comparative efficacy of etiotropic therapy of patients with HBeAg-positive chronic hepatitis B (by the data of the international comparative placebo-controlled study)]. Antibiot Khimioter (2013) 0.75

[Efficacy of cytoflavin in the treatment of chronic cerebral ischemia]. Klin Med (Mosk) (2010) 0.75

[Immunomodulators in the "gold standard" of the chronic viral hepatitis C therapy]. Antibiot Khimioter (2008) 0.75

[Personalized reamberin therapy in patients with decompensated LADA 1.5 diabetes mellitus]. Klin Med (Mosk) (2012) 0.75

[Professional medical education in Russia]. Lik Sprava (2013) 0.75

[Cycloferon, as an agent in the therapy and urgent prophylaxis of influenza and acute respiratory tract viral infection (multicentre randomized controlled comparative study)]. Antibiot Khimioter (2009) 0.75

[Correction of immunity disorders, treatment of intestinal infections and disbiosis in children (clinical review)]. Antibiot Khimioter (2010) 0.75

[Comparative evaluation of reamberin and mafusol on acute toxic liver damage models]. Eksp Klin Farmakol (2012) 0.75

[Results and prospects of interferone inducers using in infectious diseases treatment]. Vestn Ross Akad Med Nauk (2013) 0.75

[Rational approach to treatment of patients with polytrauma complicated by urinary tract infection]. Antibiot Khimioter (2010) 0.75

[Comparative study of hepatoprotective action of remaxol, reamberin and ademethionine in liver injury induced by antituberculosis drugs (experimental study)]. Antibiot Khimioter (2011) 0.75

[Positive effect of cytoflavin on metabolic status changes in patients with burn disorder]. Eksp Klin Farmakol (2011) 0.75

[Efficacy of antiviral agents in the treatment of Crimean hemorrhagic fever]. Klin Med (Mosk) (2012) 0.75

[Therapeutic efficiency of cytoflavine solution for infusion in emergency conditions]. Klin Med (Mosk) (2010) 0.75

[Pharmacological prophylaxis and treatment of recidivating respiratory disorders in children]. Eksp Klin Farmakol (2014) 0.75

[Recurrent respiratory diseases in children]. Antibiot Khimioter (2013) 0.75

[Improvement of natural resistance in children for prophylaxis of influenza and acute respiratory tract viral infections (results of multicenter randomized trials)]. Antibiot Khimioter (2009) 0.75

[Modified therapy of herpetic infection]. Klin Med (Mosk) (2011) 0.75

[Intrahepatic induction of endogenous S-adenosyl-L-methionine against the background of various ways of administration of methionine-succinate complex and its role in drug-induced liver lesion correction]. Vestn Ross Akad Med Nauk (2012) 0.75

[Combined cycloferon treatment of tuberculosis in patients infected with HIV]. Eksp Klin Farmakol (2010) 0.75

[Virus infections and interferon inducers in the complex therapy]. Antibiot Khimioter (2013) 0.75

[Use of immunomodulators in the therapy of chronic hepatitis C: improving standard approach]. Eksp Klin Farmakol (2010) 0.75

[Supportive therapy for locally advanced cancer of the oral mucosa]. Vopr Onkol (2012) 0.75

[Cycloferon--a new domestic preparation for the prophylaxis of influenza and other acute respiratory viral infections]. Zh Mikrobiol Epidemiol Immunobiol (2005) 0.75

[Gonadotoxic effects of polychlorinated biphenyls in experiments on male rats]. Antibiot Khimioter (2008) 0.75

[Characteristics of acute intestinal infection process and evaluation of pathogenetic therapy efficacy]. Antibiot Khimioter (2012) 0.75

[Syndrome "sickly child"]. Lik Sprava (2013) 0.75

[Influence of therapy with interferon inducer on the parameters of quality of life in patients with pulmonary tuberculosis]. Lik Sprava (2013) 0.75

[Immunomodulators in combined therapy of patients with chronic hepatitis]. Antibiot Khimioter (2011) 0.75

[Meglumine acridonacetate in combined antiviral treatment of HBeAg-positive chronic hepatitis B]. Georgian Med News (2013) 0.75

[Comparative study of remaxol and ademethionine effects on reparative regeneration processes in the liver subjected to surgical intervention]. Eksp Klin Farmakol (2011) 0.75

[Rational pharmacotherapy and correction of immunity disorders in children with chronic hepatitis (clinical review)]. Antibiot Khimioter (2010) 0.75

[Reamberin for pathogenetic therapy of acute and chronic viral diseases of the liver]. Klin Med (Mosk) (2010) 0.75

[Up-to-date approach to treatment of inflammatory infections in the maxillofacial region]. Antibiot Khimioter (2009) 0.75

[Correcting posthypoxic damage of myocardium in newborns with cerebral ischemia]. Eksp Klin Farmakol (2010) 0.75

[The study of the effectiveness of drug prevention mechanisms of cardiovascular aging by cytoflavin]. Adv Gerontol (2014) 0.75

[Cycloferon in the treatment of infectious diseases]. Antibiot Khimioter (2008) 0.75

[Correction of adverse reactions in antimicrobial therapy of respiratory tract tuberculosis]. Antibiot Khimioter (2008) 0.75

[Changes in the cellular reactions in children with chronic hepatitis B, and the use of immunoregulatory drugs]. Pediatriia (1984) 0.75

[Dose-dependent interferon-induction activity and pharmacokinetics of cycloferon in healthy humans]. Eksp Klin Farmakol (2012) 0.75

[Manifestations of immune deficiency in children with perinatal HIV infection in the treatment dynamics]. Antibiot Khimioter (2011) 0.75

[Pathogenetically substantiated therapy of patients with virus hepatitis C, quality of life, and the disease outcome risk (clinical survey)]. Antibiot Khimioter (2010) 0.75

[Effect of antiviral drugs with various mechanisms of action on morphogenesis of infection caused by extremely pathogenic influenza virus strains in animals]. Eksp Klin Farmakol (2011) 0.75

[Impact of antiviral therapy on psychological factors, quality of life, and ego conception in infected patients]. Antibiot Khimioter (2010) 0.75

[Chemotherapy of chronic viral hepatitis B: randomized multicenter investigation results]. Eksp Klin Farmakol (2010) 0.75

[Remaxol restores the liver antioxidant protection system in experimental cyclophosphan-induced injury]. Eksp Klin Farmakol (2011) 0.75

[Evaluation of the effectiveness of immunomodulating therapy in children with chronic gastroduodenitis]. Eksp Klin Farmakol (2013) 0.75

[Correction of immunity dysbalance in children with frequent recurrent respiratory infection]. Antibiot Khimioter (2013) 0.75

[Relationship between the endogenous interferon IFN-gamma level and risk of hepatotoxic liver damage in tuberculosis patients]. Eksp Klin Farmakol (2012) 0.75

[Reamberin optimizes drug therapy in children with acute Epstein-Barr viral infection]. Eksp Klin Farmakol (2014) 0.75

[Experience of using reamberin for detoxification therapy at the stage of deworming in children with chronic opisthorchiasis]. Eksp Klin Farmakol (2013) 0.75

[Correction of antioxidant system disorders in children with acute intestinal infection]. Eksp Klin Farmakol (2010) 0.75